POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No114/2020
Date of issue:2020-09-28
Short name of the issuer
SOPHARMA AD
Subject
Notification on the adoption of a new Policy for formation of the remuneration of the members of the Board of Directors of “Sopharma” AD
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, September 28, 2020 – In accordance with the requirements of art. 100t of LPOS “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that at the Extraordinary General Meeting of Shareholders of “Sopharma” AD, held on September 25, 2020 at 11:00 a.m. (UTC 8:00 a.m.), with a majority of 97.61% of the represented capital, in accordance with § 20 of The transitional and final provisions of Ordinance no. 48 of March 20, 2013 of the Financial Supervision Commission /promulgated, SG, no. 32 of 2.04.2013, amended and supplemented, no. 41 of 21.05.2019, amended, no. 66 of 20.08.2019, amended and supplemented, no. 61 of 10.07.2020/ a new Policy for formation of the remuneration of the members of the Board of Directors of „Sopharma“ AD was adopted. The Current Policy is available on the Company's website: https://www.sopharmagroup.com/sites/sopharma2016corp/files/3jr_remuneration_policy_2020_en_1.pdf
Annexes
FileDescription
Remuneration Policy Notification.rarNotification on the adoption of a new Policy for formation of the remuneration of the members of the Board of Directors of “Sopharma” AD
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2020-09-28Ognian DonevExecutive Director
Remuneration Policy Notification.rar

Pobierz